JAMILA FAIQ: Open Payments
NPI 1518414366 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,293 in 132 payments from 37 companies in 2025. Trend: 2023 $2,953 · 2024 $2,535 · 2025 $3,293
Food & beverage: $3,293
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $289 |
| Janssen Biotech, Inc. | 7 | $225 |
| AstraZeneca Pharmaceuticals LP | 10 | $214 |
| GENZYME CORPORATION | 5 | $175 |
| ARRAY BIOPHARMA INC | 8 | $166 |
| Novartis Pharmaceuticals Corporation | 8 | $163 |
| PFIZER INC. | 6 | $157 |
| SOBI, INC | 5 | $146 |
| BeOne Medicines USA, Inc. | 5 | $134 |
| ABBVIE INC. | 6 | $132 |
Products named: KEYTRUDA, EPKINLY, BRUKINSA, TECVAYLI, SARCLISA, Lenvima, XALKORI, Doptelet.
Industry payments across CA — which companies pay providers there.
